InvestorsHub Logo
Followers 2
Posts 13
Boards Moderated 0
Alias Born 12/08/2021

Re: None

Wednesday, 01/05/2022 3:34:08 PM

Wednesday, January 05, 2022 3:34:08 PM

Post# of 55181

Excellent questions from Vivien Azar and solid responses from the XXII team. My overall sense is "they've got this." Mish's message: Our team has come through on every target we've set. We will deliver via the pilot program (in a large, diverse city in Illinois...). FDA will be watching with XXII to make sure VLN gets the exposure to the public that is needed to help reduce the harm due to smoking, which is also FDA's mission (to foster health), via reducing smoking in the U.S. During the first quarter, as the pilot program launches in the U.S., sales will be taking place overseas (Asia) and XXII will be engaging with Brussels (E.U.) to gain their cooperation. In the U.S., individual states will be engaged to provide favorable taxation for VLN cigarettes (given decreasing rates of smoking saves lives and decreases hospitalization due to smoking-related illness; yes, it initially may sound like an oxymoronic statement but think about it). Further, in this first quarter XXII will enjoy revenue from its hemp/cannabis licensing and already has realized some from the Aurora deal. Vivien asked Jim about his reaction to the stock's decline. Jim said it is what it is. And, getting the MRTP from the FDA, though excellent, was, being delivered on 23 Dec., probably the worst time of the year for that news to come out. I did not see the 10:30 fireside chat, but the 2 pm accomplished its goals IMHO. How did others think of the 2 pm discussion?
Less
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News